113
Participants
Start Date
August 21, 2015
Primary Completion Date
January 3, 2020
Study Completion Date
January 3, 2020
SPD489
Participants will receive 5 mg of SPD489 capsule orally once daily in the morning and titrated in a step-wise fashion up to either 10 mg, 15 mg, 20 mg, or 30 mg until an optimal dose was reached.
Jersey Shore University Medical Center (JSUMC), Neptune City
Manhattan Behavioral Medicine, New York
University of Rochester, Rochester
Kennedy Krieger Institute, Baltimore
Clinical Research Partners, LLC, Petersburg
Duke Child and Family Center, Durham
Carolina Clinical Trials, Inc., Charleston
Coastal Carolina Research, Mt. Pleasant
Rainbow Research Inc, Barnwell
iResearch Atlanta LLC, Decatur
Sarkis Clinical Trials, Gainesville
Avail Clinical Research, LLC, DeLand
Medical Research Group of Central Florida, Orange City
Clinical Neuroscience Solutions, Orlando
APG Research, LLC, Orlando
University of South Florida Department Of Psychiatry, Tampa
University of South Florida, St. Petersburg
Harmonex, Inc, Dothan
Clinical Neuroscience Solutions, Inc, Memphis
University Hospitals Case Medical Center, Cleveland
Pediatric Associates of Fairfield, Inc., Fairfield
University of Cincinnati, Cincinnati
Rochester Center for Behavioral Medicine, Rochester Hills
Clinical Neurophysiology Services, Sterling Heights
Washington University, St Louis
Premier Psychiatric Reseach Institute, LLC, Lincoln
Lake Charles Clinical Trials, Lake Charles
Preferred Research Partners, Inc., Little Rock
IPS Research Company, Oklahoma City
Oklahoma Clinical Research Center, Oklahoma City
Paradigm Research Professionals, Oklahoma City
Cutting Edge Research Group, Oklahoma City
Bayou City Research Limited, Houston
BI Research Center, Houston
Red Oak Psychiatry Associates, Houston
Family Psychiatry of the Woodlands, The Woodlands
Road Runner Research, San Antonio
BioBehavioral Research of Austin, Austin
Ericksen Research and Development, Clinton
Center For Psychiatry and Behavioral Medicine In, Las Vegas
Alliance for Wellness d/b/a Alliance for Research, Long Beach
Asclepes Research, Panorama City
Psychiatric Centers at San Diego, San Diego
Sun Valley Research Center, Imperial
Elite Clinical Trials, Inc, Wildomar
AVIDA, Newport Beach
University of California, San Francisco
Cyn3rgy Research Center, Gresham
Northwest Clinical Research Center, Bellevue
Seattle Childrens Hospital, Seattle
Lead Sponsor
Shire
INDUSTRY